Investor Relations

Building the future of global cannabis.

KKOG is a vertically integrated, multi-national cannabis company with operations across Africa. We combine proprietary technology, strategic partnerships, and patient-first healthcare to drive sustainable growth.

COMPANY HIGHLIGHTS
Clients Served
0 M+
Across 400+Pharmacies/dispensaries in Africa and Globally
Countries
0
Active licensed operations and MOUs across Africa
Pharmacies
0 +

Distribution network across African Continent & EU

Land allocated
0 km+
East+West & South Africa
Financial Overview

Strong fundamentals.

Revenue Growth

Year-over-year expansion

Driven by KKOG Pharma launch and global distribution

Market Position

Industry Leader

Largest licensed cannabis company

Operational Scale

2,400L Daily Output

Cold Pressure™ extraction capacity

Geographic Reach

Multi-Continental

Presence in Africa, EU, and North America

Leadership

Experienced leadership.

Founder & CEO

Edouard “Rene” Joseph

Visionary leader with 20+ years in alternative energy and cannabis innovation

COO

Global Operations

Manages multi-national operations across 13 countries

CTO

Rehman Niazi

Oversees Cold Pressure™ extraction and pharmaceutical-grade quality standards

CFO

Finance & Strategy

Drives financial planning, investor relations, and strategic partnerships
RESOURCES

Investor documents.

Company Profile

2.4 MB • May 2026

KKOG Blank NDA

1.8 MB • April 2026

KKOG Crypto Whitepaper

3.2 MB • March 2026

KKOG Biofuel Expansion Strategy

2.1 MB • February 2026

Johannesburg Stock Exchange Listing

1.5 MB • January 2026

KKOG African Sovereign Wealth Fund

1.9 MB • December 2025

FAQ

Common questions.

Have questions about KKOG? Our investor relations team is here to help.

What is KKOG's business model?
KKOG operates as a vertically integrated cannabis company spanning cultivation, extraction, distribution, and patient care. Our Cold Pressure™ extraction technology is proprietary, and KKOG Pharma provides compliant medical access in South Africa through 1,200+ dispensaries.
KKOG will soon be listed on the Johannesburg Stok Exchange (JSE), making it the 2nd company to achieve this milestone. We also maintain headquarters in Dover, Delaware, USA with operations across 12 countries.
Davinci Group, a Swiss hedge fund managing $1B+ in assets, is a strategic investor in KKOG. This partnership provides capital for global expansion and validates our business model to institutional investors.
Our patented Cold Pressure™ extraction operates at <12 Bar and room temperature, preserving the full cannabinoid and terpene spectrum. It's GMP-certified and produces superior quality compared to CO₂ or ethanol extraction.
Key drivers include KKOG Pharma expansion (now 1,200+ locations), international distribution agreements (~4,000 pharmacies in Africa), stock exchange listings, and strategic partnerships with institutional investors.

KKOG shares are available at https://www.kkog.io, For institutional investment inquiries, distribution partnerships, or technology licensing, contact our investor relations team directly.

GET IN TOUCH

Investor inquiries.

For investment opportunities, partnership inquiries, or additional information, contact our investor relations team.

KKOG Global · Investor